Cas:34594-71-3 N,N,1-Trimethyl-1H-benzimidazol-5-amine manufacturer & supplier

We serve Chemical Name:N,N,1-Trimethyl-1H-benzimidazol-5-amine CAS:34594-71-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N,N,1-Trimethyl-1H-benzimidazol-5-amine

Chemical Name:N,N,1-Trimethyl-1H-benzimidazol-5-amine
CAS.NO:34594-71-3
Synonyms:5-Dimethylamino-1H-pyrimidin-2,4-dion;5-dimethylamino-1H-pyrimidine-2,4-dione;dimethyl-(1-methyl-1H-benzoimidazol-5-yl)-amine;5-(dimethylamino)pyrimidine-2,4(1H,3H)-dione;5-Dimethylamino-1-methylbenzimidazol;5-(dimethylamino)uracil
Molecular Formula:C10H13N3
Molecular Weight:175.23000
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:21.06000
Exact Mass:175.11100
LogP:1.63930

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-Dimethylamino-1H-pyrimidin-2,4-dion chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(dimethylamino)uracil physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(dimethylamino)uracil Use and application,5-Dimethylamino-1H-pyrimidin-2,4-dion technical grade,usp/ep/jp grade.


Related News: On top of getting compensated for the past infringements, Plexxikon says it will receive “additional royalty payments for future sales of Tafinlar in the United States through the life of the patents.” 2-(7-Methoxy-2,3-dimethyl-benzofuran-4-yl)-ethylamine manufacturers CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. 2-(4-Cyclohexylphenylmercapto)-3-methylbuten-1-ol-3 suppliers But since the emergence of the Delta variant, the health ministry has twice reported a drop in the vaccine’s efficacy against infection and a slight decrease in its protection against severe disease. 3-(3-Methoxy-phenyl)-1-(4-nitro-phenethyl)-piperidin-hydrochlorid vendor & factory.